Unlock this StockReport nowClick to Unlock

Biospecifics Technologies Income Statement

BSTC $88.53 0.0  0.0%
01/12/20
Market Cap £n/a
Revenue £26.4m
StockRank™


To unlock Biospecifics Technologies's income statement please upgrade your membership.

2014 2015 2016 2017 2018 2019
Period End: 2014-12-31 2015-12-31 2016-12-31 2017-12-31 2018-12-31 2019-12-31
Period Length: 12M 12M 12M 12M 12M 12M
Currency: USD USD USD USD USD USD
Revenue
Total Revenue
Selling/General/Administrative Expenses, Total
Research & Development
Total Operating Expense
Operating Profit/Income
Total Non Operating Interest Expense
Other, Net
Income Before Tax
Income Tax - Total
Income After Tax
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Income Available to Common Excl. Extra. Items
Income Available to Common Incl. Extra. Items
Diluted Net Income
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Incl. Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalized Income Before Taxes
Normalized Income After Taxes
Normalized Inome Avail to Common Stock
Diluted Normalized EPS
Dividends per Share - Common Stock Primary Issue


SIGNUP NOW LEARN MORE
Unlock Stockopedia Premium for free!
See what it can do for your stockpicking and portfolio at no expense.
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis